Detrusor Overactivity Completed Phase 3 Trials for Cannabidiol (DB09061)

IndicationStatusPhase
DBCOND0035562 (Detrusor Overactivity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00678795A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple SclerosisSupportive Care